An extremely interesting case in New York is examined in this article, which chronicles a female patient suffering from multiple sclerosis and her suit against her neurologist for prescribing a new medication that her attorney feels goes beyond medical malpractice and into fraud under NY’s General Business Law 349: “deceptive acts or practices in the conduct of any business, trade or commerce or in the furnishing of any service in this state are hereby declared unlawful.”